Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

Neuroscience Letters

Volumn 226, Issue 3, 1997, Pages 159-162

  French, Edward D ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

cannabinoids; electrophysiology; ventral tegmental area

Indexed keywords

CANNABINOID RECEPTOR; NALOXONE; OPIATE RECEPTOR; RIMONABANT; TETRAHYDROCANNABINOL; CANNABINOID; DOPAMINE; DRUG RECEPTOR; NARCOTIC ANTAGONIST; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; ANIMAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT; STIMULATION;

ANIMALS; CANNABINOIDS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEURONS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, OPIOID; STIMULATION, CHEMICAL; TETRAHYDROCANNABINOL; VENTRAL TEGMENTAL AREA;

EID: 0030612760     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00278-4     Document Type: Article

References (20)

1. 9-tetrahydrocannabinol in the mouse, Psychopharmacology, 57 (1978) 243-248.
2. Bloom, A.S. and Hillard, C.J., Cannabinoids, neurotransmitters, receptors, and brain membranes. In D.J. Harvey (Ed.), Marijuana '84, IRL Press, Oxford, 1985, pp. 217-231.
3. Bunney, B.S., Walters, J.R., Roth, R.H. and Aghajanian, G.K., Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther., 185 (1973) 560-571.
4. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis, Psychopharmacology, 102 (1990) 156-162.
5. French, E.D., Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of AlO dopamine neurons, Eur. J. Pharmacol., 271 (1992) 1-7.
6. French, E.D., Dillon, K. and Wu, X., Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra, NeuroReport, 8 (1997) 649-652.
7. Gardner, E.L. and Lowinson, J.H., Marijuana's interaction with brain reward systems: update 1991, Pharmacol. Biochem. Behav., 40 (1991) 571-580.
8. 9-tetrahydrocannabinol is mediated by an endogenous opioid mechanism, Adv. Biosci., 75 (1989) 671-674.
9. 9-THC impairs spatial memory through a cannabinoid receptor mechanism, Psychopharmacology, 126 (1996) 125-131.
10. 9- tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study, Brain Res., 451 (1988) 59-68.
11. Perio, A., Rinalid-Carmona, M., Maruani, J., Barth, F., Le Fur, G. and Soubrie, P., Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR141716A, Behav. Pharmacol., 7 (1996) 65-71.
12. 9-tetrahydrocannabinol-induced analgesia in mice, Eur. J. Pharmacol., 301 (1996) 75-81.
13. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.C. and Le Fur, G., SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Lett., 350 (1994) 240-244.
14. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J.C. and Le Fur, G., Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist, Life Sci., 56 (1995) 1941-1947.
15. 3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain, Life Sci., 58 (1996) 1239-1247.
16. 9-Tetrahydrocannabinol facilitates striatal dopaminergic transmission, Pharmacol. Biochem. Behav., 33 (1989) 397-400.
17. Souilhac, J., Poncelet, M., Rinalid-Carmona, M., Le Fur, G. and Soubrie, P., Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice, Pharmacol. Biochem. Behav., 51 (1995) 3-7.
18. Vayse, P.J.J., Gardner, E.L. and Zukin, R.S., Modulation of rat brain opioid receptors by cannabinoids, J. Pharmacol. Exp. Ther., 241 (1987) 534-539.
19. Welch, S.P., Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice, J. Pharmacol. Exp. Ther., 265 (1993) 633-640.
20. Wilson, R.S. and May, E.L., Analgesic properties of the tretrahydro-cannabinols, metabolites and analogs, J. Med. Chem., 18 (1975) 700-705.